In these videos, H. Ballentine Carter, MD, discusses the evidence supporting active surveillance, and Leonard S. Marks, MD, and colleagues outline which men are good candidates for surveillance.
Active surveillance for prostate cancer is the subject of the most recent installment in Urology Times' ongoing "New Frontiers in Prostate Cancer" series.
In these videos, H. Ballentine Carter, MD, discusses the evidence supporting active surveillance, and Leonard S. Marks, MD, and colleagues outline which men are good candidates for surveillance.
Diagnosing docs strongly influence PCa Tx decisions
Clinicians say active surveillance is effective but rarely recommend it
Nomogram may lower unneeded biopsies in men on AS
One-fourth of men drop out of prostate cancer surveillance
RP edges observation in young men with prostate cancer
Subscribe to Urology Times to get monthly news from the leading news source for urologists.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.